BRIEF-Ariad announces submission of marketing authorization application for Brigatinib
Feb 6 Ariad Pharmaceuticals Inc
* Ariad announces submission of marketing authorization application for Brigatinib to the European Medicines Agency
* FDA currently reviewing a NDA for Brigatinib filed by co,set action date of April 29, 2017 under prescription drug user fee act Source text for Eikon: Further company coverage:
REFILE-Oscar best actor race is tale of two opposites
LOS ANGELES, Feb 23 Denzel Washington plays a talkative, bombastic, larger-than-life dad whose personality leaps off the screen.
UPDATE 1-Nokia sees growth opportunities in networks market
BARCELONA, Feb 26 Nokia sees demand for higher speed 4G network equipment starting to recover this year, led by Japan, the company's chief executive Rajeev Suri said on Sunday as he announced a series of contracts with telecom operators.